Medication-overuse headache: The effect of a patient educational programme-A randomized controlled trial.
Journal
European journal of pain (London, England)
ISSN: 1532-2149
Titre abrégé: Eur J Pain
Pays: England
ID NLM: 9801774
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
09
05
2019
revised:
16
09
2019
accepted:
20
10
2019
pubmed:
30
10
2019
medline:
21
11
2020
entrez:
30
10
2019
Statut:
ppublish
Résumé
Little is known about the effects of non-pharmacological interventions among medication-overuse headache (MOH) patients, although non-pharmacological approaches combined with pharmacological treatment are recommended. The objective was to evaluate the effect of an educational programme as an add-on to standard treatment. Medication-overuse headache patients were randomized (1:1) in a single-centre setting to standard treatment with 12 weeks of education (I-group) versus standard treatment (C-group). The primary outcome was measurement of reduction in headache days/last month at 9 months' follow-up. Secondary outcomes were headache intensity, acute medication intake, bothersomeness, disability, physical activity and patient satisfaction. The between-group differences were analysed using a mixed-effects model for repeated measurements with a between group factor (I-group vs. C-group) and a time factor (baseline, 4 and 9 months). Ninety-eight patients were randomized (I-group: n = 48, C-group: n = 50), with 40 and 39 patients completing the study, respectively. Intention-to-treat analyses showed that both groups experienced statistically significant reductions in headache days/last month (I-group: -4 ± 6 days (95% CI 2.47; 5.95), p < .001) versus C-group: -4 ± 9 days ([95% CI 1.53; 6.79], p = .003), but there were no significant differences between groups (mean ± SE):Δ: 0.7 days ([95% CI, -2.50; 3.93], p = .66). At follow-up, 85% from the I-group and 86% from C-group, no longer fulfilled the criteria for MOH. The compliance rate was high, indicating that patients were motivated for receiving education, but we found no additional benefits of adding an educational programme to standard treatment. Future research focusing on the MOH complexity, group heterogeneity, duration and content of educational programmes is warranted. Randomized controlled trials (RCTs) of non-pharmacological intervention such as patient educational programmes are of great importance, as this approach is common in the clinical practice. Medication-overuse headache (MOH) is a heterogenetic patient group, which must be taken into account when conducting RCTs of non-pharmacological interventions. An educational programme based on Motivational Interviewing is well-tolerated among MOH patients, however, no superior effects were found from adding the educational programme to standard treatment versus standard treatment alone.
Sections du résumé
BACKGROUND
Little is known about the effects of non-pharmacological interventions among medication-overuse headache (MOH) patients, although non-pharmacological approaches combined with pharmacological treatment are recommended. The objective was to evaluate the effect of an educational programme as an add-on to standard treatment.
METHODS
Medication-overuse headache patients were randomized (1:1) in a single-centre setting to standard treatment with 12 weeks of education (I-group) versus standard treatment (C-group). The primary outcome was measurement of reduction in headache days/last month at 9 months' follow-up. Secondary outcomes were headache intensity, acute medication intake, bothersomeness, disability, physical activity and patient satisfaction. The between-group differences were analysed using a mixed-effects model for repeated measurements with a between group factor (I-group vs. C-group) and a time factor (baseline, 4 and 9 months).
RESULTS
Ninety-eight patients were randomized (I-group: n = 48, C-group: n = 50), with 40 and 39 patients completing the study, respectively. Intention-to-treat analyses showed that both groups experienced statistically significant reductions in headache days/last month (I-group: -4 ± 6 days (95% CI 2.47; 5.95), p < .001) versus C-group: -4 ± 9 days ([95% CI 1.53; 6.79], p = .003), but there were no significant differences between groups (mean ± SE):Δ: 0.7 days ([95% CI, -2.50; 3.93], p = .66). At follow-up, 85% from the I-group and 86% from C-group, no longer fulfilled the criteria for MOH.
CONCLUSION
The compliance rate was high, indicating that patients were motivated for receiving education, but we found no additional benefits of adding an educational programme to standard treatment. Future research focusing on the MOH complexity, group heterogeneity, duration and content of educational programmes is warranted.
SIGNIFICANCE
Randomized controlled trials (RCTs) of non-pharmacological intervention such as patient educational programmes are of great importance, as this approach is common in the clinical practice. Medication-overuse headache (MOH) is a heterogenetic patient group, which must be taken into account when conducting RCTs of non-pharmacological interventions. An educational programme based on Motivational Interviewing is well-tolerated among MOH patients, however, no superior effects were found from adding the educational programme to standard treatment versus standard treatment alone.
Banques de données
ClinicalTrials.gov
['NCT02768233']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
435-447Subventions
Organisme : Tryg-Foundation
Pays : International
Organisme : Carola Jørgensen Foundation
Pays : International
Organisme : Danish patient organization Migraeneog
Pays : International
Organisme : Hovedpineforeningen
Pays : International
Informations de copyright
© 2019 European Pain Federation - EFIC®.
Références
Andersen, L. G., Groenvold, M., Jorgensen, T., & Aadahl, M. (2010). Construct validity of a revised Physical Activity Scale and testing by cognitive interviewing. Scandinavian Journal of Public Health, 38(7), 707-714. https://doi.org/10.1177/1403494810380099
Andrasik, F., Buse, D. C., & Grazzi, L. (2009a). Behavioral medicine for migraine and medication overuse headache. Current Pain and Headache Reports, 13(3), 241-248. https://doi.org/10.1007/s11916-009-0041-x
Andrasik, F., Grazzi, L., Usai, S., Buse, D. C., & Bussone, G. (2009b). Non-pharmacological approaches to treating chronic migraine with medication overuse. Neurological Sciences, 30(Suppl 1), S89-93. https://doi.org/10.1007/s10072-009-0081-3
Andrasik, F., Grazzi, L., Usai, S., D'Amico, D., Kass, S., & Bussone, G. (2007). Disability in chronic migraine with medication overuse: Treatment effects at 3 years. Headache, 47(9), 1277-1281. https://doi.org/10.1111/j.1526-4610.2007.00861.x
Bendtsen, L., Birk, S., Kasch, H., Aegidius, K., Sorensen, P. S., Thomsen, L. L., Jensen, R. (2012). Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012. The Journal of Headache and Pain, 13(Suppl 1), S1-29. doi:https://doi.org/10.1007/s10194-011-0402-9.
Bendtsen, L., Munksgaard, S. B., Tassorelli, C., Nappi, G., Katsarava, Z., Lainez, M., … Jensen, R. (2014). Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia, 34(6), 426-433. https://doi.org/10.1177/0333102413515338
Bromberg, J., Wood, M. E., Black, R. A., Surette, D. A., Zacharoff, K. L., & Chiauzzi, E. J. (2012). A randomized trial of a web-based intervention to improve migraine self-management and coping. Headache, 52(2), 244-261. https://doi.org/10.1111/j.1526-4610.2011.02031.x
Cheung, V., Amoozegar, F., & Dilli, E. (2015). Medication overuse headache. Current Neurology and Neuroscience Reports, 15(1), 509. https://doi.org/10.1007/s11910-014-0509-x
Chiang, C. C., Schwedt, T. J., Wang, S. J., & Dodick, D. W. (2016). Treatment of medication-overuse headache: A systematic review. Cephalalgia, 36(4), 371-386. https://doi.org/10.1177/0333102415593088
Cupini, L. M., Sarchielli, P., & Calabresi, P. (2010). Medication overuse headache: Neurobiological, behavioural and therapeutic aspects. Pain, 150(2), 222-224. https://doi.org/10.1016/j.pain.2010.05.003
de Goffau, M. J., Klaver, A. R. E., Willemsen, M. G., Bindels, P. J. E., & Verhagen, A. P. (2017). The Effectiveness of treatments for patients with medication overuse headache: A systematic review and meta-analysis. The Journal of Pain, 18(6), 615-627. https://doi.org/10.1016/j.jpain.2016.12.005
Diener, H.-C., Dodick, D., Evers, S., Holle, D., Jensen, R. H., Lipton, R. B., … Schwedt, T. (2019). Pathophysiology, prevention, and treatment of medication overuse headache. The Lancet Neurology, 18(9), 891-902. https://doi.org/10.1016/s1474-4422(19)30146-2
Evers, S., & Marziniak, M. (2010). Clinical features, pathophysiology, and treatment of medication-overuse headache. The Lancet Neurology, 9(4), 391-401. https://doi.org/10.1016/s1474-4422(10)70008-9
Gaul, C., van Doorn, C., Webering, N., Dlugaj, M., Katsarava, Z., Diener, H. C., & Fritsche, G. (2011a). Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: An observational study. The Journal of Headache and Pain, 12(4), 475-483. https://doi.org/10.1007/s10194-011-0348-y
Gaul, C., Visscher, C. M., Bhola, R., Sorbi, M. J., Galli, F., Rasmussen, A. V., & Jensen, R. (2011b). Team players against headache: Multidisciplinary treatment of primary headaches and medication overuse headache. The Journal of Headache and Pain, 12(5), 511-519. https://doi.org/10.1007/s10194-011-0364-y
Graham, J. W., Olchowski, A. E., & Gilreath, T. D. (2007). How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prevention Science, 8(3), 206-213. https://doi.org/10.1007/s11121-007-0070-9
Gunreben-Stempfle, B., Griessinger, N., Lang, E., Muehlhans, B., Sittl, R., & Ulrich, K. (2009). Effectiveness of an intensive multidisciplinary headache treatment program. Headache, 49(7), 990-1000. https://doi.org/10.1111/j.1526-4610.2009.01448.x
Hagen, K., Jensen, R., Boe, M. G., & Stovner, L. J. (2010). Medication overuse headache: A critical review of end points in recent follow-up studies. The Journal of Headache and Pain, 11(5), 373-377. https://doi.org/10.1007/s10194-010-0221-4
Hagen, K., Linde, M., Steiner, T. J., Stovner, L. J., & Zwart, J. A. (2012). Risk factors for medication-overuse headache: An 11-year follow-up study. The Nord-Trondelag Health Studies. Pain, 153(1), 56-61. https://doi.org/10.1016/j.pain.2011.08.018
Harpole, L. H., Samsa, G. P., Jurgelski, A. E., Shipley, J. L., Bernstein, A., & Matchar, D. B. (2003). Headache management program improves outcome for chronic headache. Headache, 43(7), 715-724. https://doi.org/10.1046/j.1526-4610.2003.03128.x
Heckman, C. J., Egleston, B. L., & Hofmann, M. T. (2010). Efficacy of motivational interviewing for smoking cessation: A systematic review and meta-analysis. Tobacco Control, 19(5), 410-416. https://doi.org/10.1136/tc.2009.033175
Hjermstad, M. J., Fayers, P. M., Haugen, D. F., Caraceni, A., Hanks, G. W., Loge, J. H., … Kaasa, S. (2011). Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: A systematic literature review. Journal of Pain and Symptom Management, 41(6), 1073-1093. https://doi.org/10.1016/j.jpainsymman.2010.08.016
ICHD (2013). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia, 33(9), 629-808. https://doi.org/10.1177/0333102413485658
ICHD (2018). Headache Classification Committee of the International Headache Society (IHS) the international classification of headache disorders. Cephalalgia, 38(1), 1-211. https://doi.org/10.1177/0333102417738202
Katsarava, Z., Muessig, M., Dzagnidze, A., Fritsche, G., Diener, H. C., & Limmroth, V. (2005). Medication overuse headache: Rates and predictors for relapse in a 4-year prospective study. Cephalalgia, 25(1), 12-15. https://doi.org/10.1111/j.1468-2982.2004.00789.x
Kristoffersen, E. S., & Lundqvist, C. (2014). Medication-overuse headache: Epidemiology, diagnosis and treatment. Therapeutic Advances in Drug Safety, 5(2), 87-99. https://doi.org/10.1177/2042098614522683
Kristoffersen, E. S., Straand, J., Russell, M. B., & Lundqvist, C. (2016). Disability, anxiety and depression in patients with medication-overuse headache in primary care - the BIMOH study. European Journal of Neurology, 23(Suppl 1), 28-35. https://doi.org/10.1111/ene.12850
Kristoffersen, E. S., Straand, J., Vetvik, K. G., Benth, J. S., Russell, M. B., & Lundqvist, C. (2015). Brief intervention for medication-overuse headache in primary care. The BIMOH study: A double-blind pragmatic cluster randomised parallel controlled trial. Journal of Neurology, Neurosurgery and Psychiatry, 86(5), 505-512. https://doi.org/10.1136/jnnp-2014-308548
Lake, A. E., 3rd (2006). Medication overuse headache: Biobehavioral issues and solutions. Headache, 46(Suppl 3), S88-97. https://doi.org/10.1111/j.1526-4610.2006.00560.x
Lundahl, B., Moleni, T., Burke, B. L., Butters, R., Tollefson, D., Butler, C., & Rollnick, S. (2013). Motivational interviewing in medical care settings: A systematic review and meta-analysis of randomized controlled trials. Patient Education and Counseling, 93(2), 157-168. https://doi.org/10.1016/j.pec.2013.07.012
Matchar, D. B., Harpole, L., Samsa, G. P., Jurgelski, A., Lipton, R. B., Silberstein, S. D., … Blumenfeld, A. (2008). The headache management trial: A randomized study of coordinated care. Headache, 48(9), 1294-1310. https://doi.org/10.1111/j.1526-4610.2007.01148.x
Miller, W. R., & Rollnick, S. (1991). Motivational interviewing. Preparing people to change addictive behavior. New York: Guilford press.
Munksgaard, S. B., Bendtsen, L., & Jensen, R. H. (2012). Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: A comparison of two consecutive treatment methods in an open-label design. Cephalalgia, 32(11), 834-844. https://doi.org/10.1177/0333102412451363
Olesen, J. (2012). Detoxification for medication overuse headache is the primary task. Cephalalgia, 32(5), 420-422. https://doi.org/10.1177/0333102411431309
Paemeleire, K., Evers, S., & Goadsby, P. J. (2008). Medication-overuse headache in patients with cluster headache. Current Pain and Headache Reports, 12(2), 122-127. https://doi.org/10.1007/s11916-008-0023-4
Prochaska, J. O., & DiClemente, C. C. (1986). Toward a comprehensive model of change. New York, NY: Plenum Press.
Rapoport, A. M. (2008). Medication overuse headache: Awareness, detection and treatment. CNS Drugs, 22(12), 995-1004. https://doi.org/10.2165/0023210-200822120-00003
Rogers, C. R. (1951). Client-centered therapy: Its current practice, implications and theory. Boston: Houghton Mifflin Boston.
Rossi, P., Di Lorenzo, C., Faroni, J., Cesarino, F., & Nappi, G. (2006). Advice alone vs. structured detoxification programmes for medication overuse headache: A prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia, 26(9), 1097-1105. https://doi.org/10.1111/j.1468-2982.2006.01175.x
Rossi, P., Jensen, R., Nappi, G., & Allena, M. (2009). A narrative review on the management of medication overuse headache: The steep road from experience to evidence. The Journal of Headache and Pain, 10(6), 407-417. https://doi.org/10.1007/s10194-009-0159-6
Rubak, S., Sandbaek, A., Lauritzen, T., & Christensen, B. (2005). Motivational interviewing: A systematic review and meta-analysis. British Journal of General Practice, 55(513), 305-312.
Russell, M. B., & Lundqvist, C. (2012). Prevention and management of medication overuse headache. Current Opinion in Neurology, 25(3), 290-295. https://doi.org/10.1097/WCO.0b013e328352c431
Saper, J. R., Hamel, R. L., & Lake, A. E., 3rd (2005). Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia, 25(7), 545-546. https://doi.org/10.1111/j.1468-2982.2005.00879.x
Stewart, M., Maher, C. G., Refshauge, K. M., Bogduk, N., & Nicholas, M. (2007). Responsiveness of pain and disability measures for chronic whiplash. Spine (Phila Pa 1976), 32(5), 580-585. https://doi.org/10.1097/01.brs.0000256380.71056.6d
Stewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (2001). Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology, 56(6 Suppl 1), S20-28. https://doi.org/10.1212/WNL.56.suppl_1.S20
Stewart, W. F., Lipton, R. B., Whyte, J., Dowson, A., Kolodner, K., Liberman, J. N., & Sawyer, J. (1999). An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology, 53(5), 988-994. https://doi.org/10.1212/WNL.53.5.988
Wallasch, T. M., Angeli, A., & Kropp, P. (2012). Outcomes of a headache-specific cross-sectional multidisciplinary treatment program. Headache, 52(7), 1094-1105. https://doi.org/10.1111/j.1526-4610.2012.02189.x
Wallasch, T. M., & Kropp, P. (2012). Multidisciplinary integrated headache care: A prospective 12-month follow-up observational study. The Journal of Headache and Pain, 13(7), 521-529. https://doi.org/10.1007/s10194-012-0469-y
Westergaard, M. L., Glumer, C., Hansen, E. H., & Jensen, R. H. (2016). Medication overuse, healthy lifestyle behaviour and stress in chronic headache: Results from a population-based representative survey. Cephalalgia, 36(1), 15-28. https://doi.org/10.1177/0333102415578430
Zeeberg, P., Olesen, J., & Jensen, R. (2006). Probable medication-overuse headache: The effect of a 2-month drug-free period. Neurology, 66(12), 1894-1898. https://doi.org/10.1212/01.wnl.0000217914.30994.bd
Zomahoun, H. T. V., Guénette, L., Grégoire, J.-P., Lauzier, S., Lawani, A. M., Ferdynus, C., … Moisan, J. (2017). Effectiveness of motivational interviewing interventions on medication adherence in adults with chronic diseases: A systematic review and meta-analysis. International Journal of Epidemiology, 46(2), 589-602. https://doi.org/10.1093/ije/dyw273